articleTop 1% cited
A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions
British Journal of Dermatology · 2012 · Vol. 168(3) · pp. 555–562
A. Barbaud✉(Centre Hospitalier Régional et Universitaire de Nancy)E. Collet(Maison des Sciences de l’Homme de Dijon)B. Milpied(Université de Bordeaux)H. Assier(Hôpitaux Universitaires Henri-Mondor)D. StaumontM. Avenel-Audran(Centre Hospitalier Universitaire d'Angers)A. Grange(Centre Hospitalier Universitaire de Reims)S. AmargerP. Girardin(Hôpital Saint-Jacques)M.T. Guinnepain(Institut Pasteur)F. Truchetet(Centre Hospitalier Régional de Metz-Thionville)A. Lasek(Hôpital Saint-Philibert)J. Waton(Université de Lorraine)on behalf of the Toxidermies group of the French Society of Dermatology
Abstract
PTs are useful and safe for identifying agents inducing SCAR.
Drug-Induced Adverse ReactionsAutoimmune Bullous Skin DiseasesContact Dermatitis and AllergiesMedicineUniversity hospitalDermatologyLibrary scienceFamily medicineComputer science
MeSH terms
AdolescentAdultAgedAged, 80 and overDrug EruptionsDrug InteractionsEosinophiliaFemaleHumansMaleMiddle AgedPatch TestsStevens-Johnson SyndromeTime FactorsYoung Adult
Citations
382
FWCI
14.61
field-weighted impact
References
34
Percentile
99%
vs. same field & year
Citations per year
Cited by
International<scp>Con</scp>sensus on drug allergy
Allergy · 2014 · 906 citations
References
General considerations for skin test procedures in the diagnosis of drug hypersensitivity
Allergy · 2002 · 699 citations
Risk factors for acute generalized exanthematous pustulosis (AGEP)—results of a multinational case–control study (EuroSCAR)
British Journal of Dermatology · 2007 · 555 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.